n | % | ||
---|---|---|---|
Age at the time of diagnosis (n=1036) | <65 | 774 | 74.7 |
65-69 | 102 | 9.8 | |
70-74 | 92 | 8.9 | |
≥75 | 68 | 6.6 | |
Year of diagnosis (n=1036) | 2000 | 147 | 14.2 |
2001 | 137 | 13.2 | |
2002 | 131 | 12.6 | |
2003 | 152 | 14.7 | |
2004 | 143 | 13.8 | |
2005 | 164 | 15.8 | |
2006 | 162 | 15.6 | |
Comorbidity (n=690) | No | 557 | 80.7 |
Yes | 133 | 19.3 | |
Stage (n=912) | 1 | 208 | 22.8 |
2 | 415 | 45.5 | |
3 | 197 | 21.6 | |
4 | 92 | 10.1 | |
Histology (n=1012) | Invasive ductal ca | 473 | 46.7 |
Invasive lobular ca | 220 | 21.7 | |
Mixed | 182 | 18.0 | |
Others | 137 | 13.5 | |
Histologic grade (n=745) | 1 | 119 | 16.0 |
2 | 338 | 45.3 | |
3 | 288 | 38.7 | |
Lymphovascular invasion (n=849) | No | 174 | 20.5 |
Yes | 675 | 79.5 | |
Surgery (n=1010) | No | 52 | 5.1 |
Yes | 958 | 94.9 | |
Chemotherapy (n=824) | No | 187 | 22.7 |
Yes | 637 | 77.3 | |
Radiotherapy (n=794) | No | 28 | 3.5 |
Yes | 766 | 96.5 | |
Hormonotherapy (n=703) | No | 113 | 16.1 |
Yes | 590 | 83.9 | |
Recurrence (n=545) | No | 490 | 89.9 |
Yes | 55 | 10.1 | |
Metastases (n=608) | No | 415 | 68.3 |
Yes | 193 | 31.7 |